Epidemiologic studies of polyomaviruses and cancer: Previous findings, methodologic challenges and future directions

Advances in Experimental Medicine and Biology

Volumn 577, Issue , 2006, Pages 342-356

  Rollison, Dana E M ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; FORECASTING; HUMAN; ISOLATION AND PURIFICATION; NEOPLASM; PATHOPHYSIOLOGY; POLYOMA VIRUS; REVIEW; VIROLOGY; VIRUS INFECTION;

ANIMALS; FORECASTING; HUMANS; NEOPLASMS; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS;

EID: 33745629130     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-32957-9_24     Document Type: Review

References (32)

1. Sweet BH, Hillemann MR. The vacuolating virus, SV40. Proc Soc Exp Biol Med 1960; 105:420-427.
2. Eddy BE, Borman GS, Berkeley WH et al. Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med 1961; 107:191-197.
3. Shah K, Nathanson N. Human exposure to SV40: Review and comment. Am J Epidemiol 1976; 103(1):1-12.
4. Fraumeni Jr JF, Ederer FE, Miller RW. An evaluation of the carcinogenicity of simian virus 40 in man. JAMA 1963; 185(9):713-718.
5. Innis MD. Oncogenesis and poliomyelitis vaccine. Nature 1968; 219(157):972-973.
6. Stewart AM, Hewitt D. Aetiology of childhood leukaemia. Lancet 1965; 2(7416):789-790.
7. Farwell JR, Dohrmann GJ, Marrett LD et al. Effect of SV40 virus-contaminated polio vaccine on the incidence and type of CNS neoplasms in children: A population-based study. Trans Am Neurol Assoc 1979; 104:261-264.
8. Heinonen OP, Shapiro S, Monson RR et al. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973; 2(3):229-235.
9. Mortimer Jr EA, Lepow ML, Gold E et al. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. N Engl J Med 1981; 365(25):1517-1518.
10. Bergsagel DJ, Finegold MJ, Butel JS et al. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 1992; 326(15):988-993.
11. CarroU-Pankhurst C, Engels EA, Strickler HD et al. Thirty-five year mortality following receipt of Br J Cancer 2001; 85(9):1295-1297.
12. Fisher SG, Weber L, Carbone M. Cancer risk associated with simian virus 40 contaminated polio vaccine. Anticancer Res 1999; 19(3B):2173-2180.
13. Geissler E. SV40 and human brain tumors. Prog Med Virol 1990; 37:211-222.
14. Olin P, Giesecke J. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: No impact on cancer incidence rates 1960 to 1993. Dev Biol Stand 1998; 94:227-233.
15. Strickler HD, Rosenberg PS, Devesa SS et al. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 1998; 279(4):292-295.
16. Strickler HD, Rosenberg PS, Devesa SS et al. Contamination of poliovirus vaccine with SV40 and the incidence of medulloblastoma. Med Pediatr Oncol 1999; 32(1):77-78.
17. RoUison DEM, Shah KV. The epidemiology of SV40 infection due to contaminated polio vaccines: Relation of the virus to human cancer. In: Khalili K, Stoner GL, eds. Human polyomaviruses: Molecular and clinical perspectives. Wiley-Liss Inc., 2002:561-584.
18. Strickler HD, Goedert JJ. Exposure to SV40-contaminated poliovirus vaccine and the risk of cancer - a review of the epidemiological evidence. Dev Biol Stand 1998; 94:235-244.
19. Brenner AV, Linet MS, Selker RG et al. Polio vaccination and risk of brain tumors in adults: No apparent association. Cancer Epidemiol Biomarkers Prev 2003; 12(2):177-178.
20. de Sanjose S, Shah KV, Domingo-Domenech E et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 2003; 104(4):522-524.
21. Engels EA, Rodman LH, Frisch M et al. Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma. Int J Cancer 2003; 106(2):283-287.
22. Engels EA, Katki HA, Nielsen NM et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003; 95(7):532-539.
23. Holly EA, Bracci PM. Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. Am J Epidemiol 2003; 158(4):316-327.
24. Rollison DE, Helzlsouer KJ, Alberg AJ et al. Serum Antibodies to JC Virus, BK Virus, Simian Virus 40, and the Risk of Incident Adult Astrocytic Brain Tumors. Cancer Epidemiol Biomarkers Prev 2003; 12(5):460-463.
25. Strickler HD, Goedert JJ, Devesa SS et al. Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst 2003; 95(1):38-45.
26. Priftakis P, Dalianis T, Carstensen J et al. Human polyomavirus DNA is not detected in Guthrie cards (dried blood spots) from children who developed acute lymphoblastic leukemia. Med Pediatr Oncol 2003; 40(4):219-223.
27. Fraumeni Jr JF, Stark CR, Gold E et al. Simian virus 40 in polio vaccine: Follow-up of newborn recipients. Science 1970; 167(914):59-60.
28. Khalili K, Del Valle L, Otte J et al. Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene 2003; 22(33):5181-5191.
29. Viscidi RP, Rollison DE, Viscidi E et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003; 10(2):278-285.
30. Shah KV. Polyomaviruses. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. Philadelphia: Lippincott-Raven, 1996:2027-2043.
31. Malkin D, Chilton-MacNeill S, Meister LA et al. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene 2001; 20(33) :4441-4449.
32. Birch JM, Alston RD, McNally RJ et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 2001; 20(34):4621-4628.